New asthma model aimed to shorten phase II trials and inform decisions on phase III

Treatments improving: diary-based symptom score, diary-based rescue medication use, and/or FEV1 should also produce a better outcome in exacerbations in asthma patients; this is what the study conducted by Robin Svensson, Jakob Ribbing, Mats Karlsson and Genentech collaborators determined.

Read more here: